Letters

All Items

Letters may deliver information or news regarding an issue related to the Journal scope. If the letter relates to a published manuscript, the authors of the original manuscript will be given the opportunity to provide a response. Authors of Letters to the Editor should provide a short title. [800 words max]

What is the gender of thrombosis? A natural model of precision medicine

Rossella Marcucci, Rosanna Abbate

https://doi.org/10.4081/btvb.2023.87

457

PDF: 159
Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

https://doi.org/10.4081/btvb.2022.28

5176

PDF: 439

APPENDIX: 114
Thrombotic thrombocytopenic purpura: much done, but still a lot to do

Paola Binetti

https://doi.org/10.4081/btvb.2024.149

471

PDF: 155
The metaphor of Ukrainian science <i>bleeding”</i>

Gaetano Torlone

https://doi.org/10.4081/btvb.2023.73

273

PDF: 165
The diagnostic procedure for subjects with suspected pulmonary embolism. A recent comparison among the recommendations available from the international guidelines

Gualtiero Palareti

https://doi.org/10.4081/btvb.2024.122

848

PDF: 223

Supplementary Material: 36
Synthetic platelets: can bioengineering realize in few years what evolution made in over 200 million years?

Paolo Gresele

https://doi.org/10.4081/btvb.2024.148

1757

PDF: 333
Science and scientists under attack

Valerio De Stefano

https://doi.org/10.4081/btvb.2023.80

306

PDF: 148
ReDIP, the Italian network for the diagnosis of congenital platelet function disorders

Marco Cattaneo, Claudia Ghali, Mariangela Scavone

https://doi.org/10.4081/btvb.2024.134

321

PDF: 103
Platelet transcriptomic changes in myocardial infarction are sex and clinical subtype-related: a step forward towards precision medicine?

Loredana Bury, Alessio Branchini, Francesco Bernardi, Paolo Gresele

https://doi.org/10.4081/btvb.2025.173

98

PDF: 38
Palestinian patients associations appeal on World Hemophilia Day

Sara Mellano

https://doi.org/10.4081/btvb.2024.136

299

PDF: 84
In memoriam of Professor Bruno Bizzi (1927-2023)

Valerio De Stefano

https://doi.org/10.4081/btvb.2023.110

132

PDF: 111
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

Anna Falanga, Hugo Ten Cate, Bianca Rocca

https://doi.org/10.4081/btvb.2023.60

630

PDF: 282
Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

Ottavia Borghese, Claudio Vincenzoni

https://doi.org/10.4081/btvb.2024.141

963

PDF: 238
A contribution from Umberto Veronesi Foundation

Chiara Tonelli

https://doi.org/10.4081/btvb.2023.74

247

PDF: 126

Letters

All Items

What is the gender of thrombosis? A natural model of precision medicine

Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

Thrombotic thrombocytopenic purpura: much done, but still a lot to do

The metaphor of Ukrainian science <i>bleeding”</i>

The diagnostic procedure for subjects with suspected pulmonary embolism. A recent comparison among the recommendations available from the international guidelines

Synthetic platelets: can bioengineering realize in few years what evolution made in over 200 million years?

Science and scientists under attack

ReDIP, the Italian network for the diagnosis of congenital platelet function disorders

Platelet transcriptomic changes in myocardial infarction are sex and clinical subtype-related: a step forward towards precision medicine?

Palestinian patients associations appeal on World Hemophilia Day

In memoriam of Professor Bruno Bizzi (1927-2023)

How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

A contribution from Umberto Veronesi Foundation

flyer

authors

reviewers

indexing

Categories

aice

Keywords